Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatmentsRosanna Coppo, Agnieszka Perkowska‐Ptasińska, Sigrid Lunberg et al.|Kidney International|2014Cited by 506
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohortRosanna Coppo, Eva Honsová, Danilo Lofaro et al.|Pediatric Nephrology|2016Cited by 93
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohortShubha S. Bellur, Regina Tardanico, Ian S.D. Roberts et al.|Nephrology Dialysis Transplantation|2018Cited by 74
Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohortRosanna Coppo, Eva Honsová, Danilo Lofaro et al.|Pediatric Nephrology|2016Cited by 4
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohortShubha S. Bellur, Regina Tardanico, Ian S D Roberts et al.|Nephrology Dialysis Transplantation|2019Cited by 4